{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:01:10Z","timestamp":1780124470587,"version":"3.54.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-06978-4","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T09:43:34Z","timestamp":1777196614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune liver diseases and overlap syndromes in children with inflammatory bowel diseases"],"prefix":"10.1007","volume":"185","author":[{"given":"Giovanna Fernanda","family":"Vazzana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Del Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"issue":"2","key":"6978_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MPG.0000000000001455","volume":"65","author":"T Greuter","year":"2017","unstructured":"Greuter T, Bertoldo F, Rechner R et al (2017) Extraintestinal manifestations of pediatric inflammatory bowel disease: prevalence, presentation, and anti-TNF treatment. J Pediatr Gastroenterol Nutr 65(2):200\u2013206. https:\/\/doi.org\/10.1097\/MPG.0000000000001455","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"6978_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41430-019-0490-1","volume":"74","author":"S Cohen","year":"2020","unstructured":"Cohen S, Padlipsky J, Yerushalmy-Feler A (2020) Risk factors associated with extraintestinal manifestations in children with inflammatory bowel disease. Eur J Clin Nutr 74(5):691\u2013697. https:\/\/doi.org\/10.1038\/s41430-019-0490-1","journal-title":"Eur J Clin Nutr"},{"issue":"22","key":"6978_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225359","volume":"10","author":"U Daniluk","year":"2021","unstructured":"Daniluk U, Kwiatek-Sredzinska K, Jakimiec P et al (2021) Liver pathology in children with diagnosed inflammatory bowel disease-a single center experience. J Clin Med 10(22):5359. https:\/\/doi.org\/10.3390\/jcm10225359","journal-title":"J Clin Med"},{"issue":"2","key":"6978_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MPG.0000000000001078","volume":"63","author":"M Bramuzzo","year":"2016","unstructured":"Bramuzzo M, Martelossi S, Torre G et al (2016) Clinical features and risk factors of autoimmune liver involvement in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 63(2):259\u2013264. https:\/\/doi.org\/10.1097\/MPG.0000000000001078","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"6978_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/jpn3.12378","volume":"80","author":"PF van Rheenen","year":"2025","unstructured":"van Rheenen PF, Kolho KL, Russell RK, Aloi M, Deganello A, Hussey S, Junge N, De Laffolie J, Deneau MR, Fitzpatrick E, Griffiths AM, Hojsak I, Nicastro E, Nita A, Pakarinen M, Ricciuto A, de Ridder L, Sonzogni A, Tenca A, Samyn M, Indolfi G (2025) Primary sclerosing cholangitis in children with inflammatory bowel disease: an ESPGHAN position paper from the Hepatology Committee and the IBD Porto group. J Pediatr Gastroenterol Nutr 80(2):374\u2013393. https:\/\/doi.org\/10.1002\/jpn3.12378","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"6978_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jhep.2023.02.030","volume":"79","author":"A Ricciuto","year":"2023","unstructured":"Ricciuto A, Kamath BM, Hirschfield GM et al (2023) Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: a coming of age or an age-ist problem? J Hepatol 79(2):567\u2013575. https:\/\/doi.org\/10.1016\/j.jhep.2023.02.030","journal-title":"J Hepatol"},{"issue":"4","key":"6978_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/HEP.0000000000000926","volume":"82","author":"R Kellermayer","year":"2025","unstructured":"Kellermayer R, Carbone M, Horvath TD, Szigeti RG, Buness C, Hirschfield GM, Lewindon PJ (2025) Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: embryology and the overlap of inflammatory bowel disease with immune-mediated liver injury. Hepatology 82(4):949\u2013959. https:\/\/doi.org\/10.1097\/HEP.0000000000000926","journal-title":"Hepatology"},{"issue":"4","key":"6978_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.dld.2021.06.028","volume":"54","author":"A Di Giorgio","year":"2022","unstructured":"Di Giorgio A, Vergani D, Mieli-Vergani G (2022) Cutting edge issues in juvenile sclerosing cholangitis. Dig Liver Dis 54(4):417\u2013427. https:\/\/doi.org\/10.1016\/j.dld.2021.06.028","journal-title":"Dig Liver Dis"},{"key":"6978_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaut.2018.10.008","volume":"95","author":"B Terziroli Beretta-Piccoli","year":"2018","unstructured":"Terziroli Beretta-Piccoli B, Vergani D, Mieli-Vergani G (2018) Autoimmune sclerosing cholangitis: evidence and open questions. J Autoimmun 95:15\u201325. https:\/\/doi.org\/10.1016\/j.jaut.2018.10.008","journal-title":"J Autoimmun"},{"issue":"2","key":"6978_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","volume":"66","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Baumann U et al (2018) Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee position statement. J Pediatr Gastroenterol Nutr 66(2):345\u2013360. https:\/\/doi.org\/10.1097\/MPG.0000000000001801","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"6978_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN et al (2020) Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology 72(2):671\u2013722. https:\/\/doi.org\/10.1002\/hep.31065","journal-title":"Hepatology"},{"key":"6978_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jaut.2018.10.007","volume":"95","author":"C Sokollik","year":"2018","unstructured":"Sokollik C, McLin VA, Vergani D et al (2018) Juvenile autoimmune hepatitis: a comprehensive review. J Autoimmun 95:69\u201376. https:\/\/doi.org\/10.1016\/j.jaut.2018.10.007","journal-title":"J Autoimmun"},{"issue":"3","key":"6978_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/jhep.2001.22131","volume":"33","author":"GV Gregorio","year":"2001","unstructured":"Gregorio GV, Portmann B, Karani J et al (2001) Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33(3):544\u2013553. https:\/\/doi.org\/10.1053\/jhep.2001.22131","journal-title":"Hepatology"},{"issue":"4","key":"6978_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1055\/a-2679-3641","volume":"45","author":"S Wei","year":"2025","unstructured":"Wei S, Lu J (2025) Microbial modulation of the gut-liver axis in autoimmune liver diseases. Semin Liver Dis 45(4):498\u2013516. https:\/\/doi.org\/10.1055\/a-2679-3641","journal-title":"Semin Liver Dis"},{"issue":"3","key":"6978_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","volume":"159","author":"DM Chopyk","year":"2020","unstructured":"Chopyk DM, Grakoui A (2020) Contribution of the intestinal microbiome and gut barrier to hepatic disorders. Gastroenterology 159(3):849\u2013863. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.077","journal-title":"Gastroenterology"},{"issue":"4","key":"6978_CR16","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.26454","volume":"58","author":"M Deneau","year":"2013","unstructured":"Deneau M, Jensen MK, Holmen J et al (2013) Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology 58(4):1392\u20131400. https:\/\/doi.org\/10.1002\/hep.26454","journal-title":"Hepatology"},{"issue":"3","key":"6978_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MPG.0000000000000409","volume":"59","author":"A Goyal","year":"2014","unstructured":"Goyal A, Hyams JS, Lerer T et al (2014) Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver disease. J Pediatr Gastroenterol Nutr 59(3):321\u2013323. https:\/\/doi.org\/10.1097\/MPG.0000000000000409","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"6978_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.32771","volume":"77","author":"CL Bowlus","year":"2023","unstructured":"Bowlus CL, Arriv\u00e9 L, Bergquist A et al (2023) AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 77(2):659\u2013702. https:\/\/doi.org\/10.1002\/hep.32771","journal-title":"Hepatology"},{"key":"6978_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jpeds.2021.07.047","volume":"238","author":"KO Hensel","year":"2021","unstructured":"Hensel KO, Kyrana E, Hadzic N et al (2021) Sclerosing cholangitis in pediatric inflammatory bowel disease: early diagnosis and management affect clinical outcome. J Pediatr 238:50-56.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2021.07.047","journal-title":"J Pediatr"},{"issue":"4","key":"6978_CR20","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/hep.31893","volume":"74","author":"Y Ma","year":"2021","unstructured":"Ma Y, Su H, Yuksel M, Longhi MS, McPhail MJ, Wang P, Bansal S, Wong GW, Graham J, Yang L, Thompson JR, Doherty DG, Hadzic N, Zen Y, Quaglia A, Heneghan MA, Samyn M, Vergani D, Mieli-Vergani G (2021) Human leukocyte antigen profile predicts severity of autoimmune liver disease in children of European ancestry. Hepatology 74(4):2032\u20132046. https:\/\/doi.org\/10.1002\/hep.31893.","journal-title":"Hepatology"},{"key":"6978_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2025.103436","volume":"154","author":"P Wang","year":"2025","unstructured":"Wang P, Yuksel M, Gabeta S, Graham J, Hussain M, Blackmore LJ, Huang X, Hadzic D, Samyn M, Grammatikopoulos T, Heneghan M, Liberal R, Longhi MS, Mieli-Vergani G, Vergani D, Ma Y (2025) HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives. J Autoimmun 154:103436. https:\/\/doi.org\/10.1016\/j.jaut.2025.103436","journal-title":"J Autoimmun"},{"issue":"1","key":"6978_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2023.03.238","volume":"165","author":"AJ Noble","year":"2023","unstructured":"Noble AJ, Nowak JK, Adams AT, Uhlig HH, Satsangi J (2023) Defining interactions between the genome, epigenome, and the environment in inflammatory bowel disease: progress and prospects. Gastroenterology 165(1):44-60.e2. https:\/\/doi.org\/10.1053\/j.gastro.2023.03.238","journal-title":"Gastroenterology"},{"issue":"1","key":"6978_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jhep.2016.09.002","volume":"66","author":"EK Henriksen","year":"2017","unstructured":"Henriksen EK, J\u00f8rgensen KK, Kaveh F, Holm K, Hamm D, Olweus J, Melum E, Chung BK, Eide TJ, Lundin KE, Boberg KM, Karlsen TH, Hirschfield GM, Liaskou E (2017) Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease. J Hepatol 66(1):116\u2013122. https:\/\/doi.org\/10.1016\/j.jhep.2016.09.002","journal-title":"J Hepatol"},{"key":"6978_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1206025","volume":"14","author":"A Grama","year":"2023","unstructured":"Grama A, Mititelu A, S\u00eerbe C, Ben\u0163a G, Pop TL (2023) Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets. Front Immunol 14:1206025. https:\/\/doi.org\/10.3389\/fimmu.2023.1206025","journal-title":"Front Immunol"},{"key":"6978_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/MPG.0000000000001492","volume":"64","author":"LJ Saubermann","year":"2017","unstructured":"Saubermann LJ, Deneau M, Falcone RA, Murray KF, Ali S, Kohli R, Ekong UD, Valentino PL, Grossman AB, Rand EB, Jonas MM, Saeed SA, Kamath BM (2017) Hepatic issues and complications associated with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 64:639\u2013652. https:\/\/doi.org\/10.1097\/MPG.0000000000001492","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"6978_CR26","first-page":"1415","volume":"22","author":"M Wilschanski","year":"1995","unstructured":"Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St Louis P, Griffiths AM, Blendis LM, Moroz SP, Scully L et al (1995) Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 22(5):1415\u20131422","journal-title":"Hepatology"},{"issue":"2","key":"6978_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/hep.29204","volume":"66","author":"MR Deneau","year":"2017","unstructured":"Deneau MR, El-Matary W et al (2017) The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology 66(2):518\u2013527. https:\/\/doi.org\/10.1002\/hep.29204","journal-title":"Hepatology"},{"issue":"7","key":"6978_CR28","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.cgh.2019.08.048","volume":"18","author":"A Ricciuto","year":"2020","unstructured":"Ricciuto A, Hansen BE, Ngo B, Aloi M, Walters TD, Church PC, Mazurek A, Khan M, Carman N, Siddiqui I, Nguyen GC, Kamath BM, Griffiths AM (2020) Primary sclerosing cholangitis in children with inflammatory bowel diseases is associated with milder clinical activity but more frequent subclinical inflammation and growth impairment. Clin Gastroenterol Hepatol 18(7):1509-1517.e7. https:\/\/doi.org\/10.1016\/j.cgh.2019.08.048","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"6978_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/hep.27191","volume":"60","author":"RH Squires","year":"2014","unstructured":"Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, Mazariegos GV (2014) Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology 60(1):362\u2013398. https:\/\/doi.org\/10.1002\/hep.27191","journal-title":"Hepatology"},{"issue":"5","key":"6978_CR30","doi-asserted-by":"publisher","first-page":"e1237","DOI":"10.1542\/peds.2015-0578","volume":"136","author":"C Jim\u00e9nez-Rivera","year":"2015","unstructured":"Jim\u00e9nez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez F (2015) Incidence and characteristics of autoimmune hepatitis. Pediatrics 136(5):e1237-48. https:\/\/doi.org\/10.1542\/peds.2015-0578","journal-title":"Pediatrics"},{"issue":"10","key":"6978_CR31","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/ibd\/izad218","volume":"30","author":"G Catassi","year":"2024","unstructured":"Catassi G, D\u2019Arcangelo G, Norsa L, Bramuzzo M, Hojsak I, Kolho KL, Romano C, Gasparetto M, Di Giorgio A, Hussey S, Yerushalmy-Feler A, Turner D, Matar M, Weiss B, Karoliny A, Alvisi P, Tzivinikos C, Aloi M (2024) Outcome of very early onset inflammatory bowel disease associated with primary sclerosing cholangitis: a multicenter study from the Pediatric IBD Porto Group of ESPGHAN. Inflamm Bowel Dis 30(10):1662\u20131669. https:\/\/doi.org\/10.1093\/ibd\/izad218","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"6978_CR32","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1097\/MIB.0000000000000558","volume":"21","author":"PL Valentino","year":"2015","unstructured":"Valentino PL, Feldman BM, Walters TD et al (2015) Abnormal liver biochemistry is common in pediatric inflammatory bowel disease: prevalence and associations. Inflamm Bowel Dis 21(12):2848\u20132856. https:\/\/doi.org\/10.1097\/MIB.0000000000000558","journal-title":"Inflamm Bowel Dis"},{"key":"6978_CR33","doi-asserted-by":"publisher","unstructured":"Mendes FD, Levy C, Enders FB, Loftus EV Jr, Angulo P, Lindor KD (2007) Abnormal hepatic biochemistries in patients with inflammatory bowel disease. Am J Gastroenterol 102(2):344\u201350. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00947.x","DOI":"10.1111\/j.1572-0241.2006.00947.x"},{"issue":"3","key":"6978_CR34","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/hep.31393","volume":"73","author":"MR Deneau","year":"2021","unstructured":"Deneau MR, Mack C et al (2021) The sclerosing cholangitis outcomes in pediatrics (SCOPE) index: a prognostic tool for children. Hepatology 73(3):1074\u20131087. https:\/\/doi.org\/10.1002\/hep.31393","journal-title":"Hepatology"},{"issue":"2","key":"6978_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/MPG.0000000000001789","volume":"66","author":"JM Cotter","year":"2018","unstructured":"Cotter JM, Browne LP, Capocelli KE, McCoy A, Mack CL (2018) Lack of correlation of liver tests with fibrosis stage at diagnosis in pediatric primary sclerosing cholangitis. J Pediatr Gastroenterol Nutr 66(2):227\u2013233. https:\/\/doi.org\/10.1097\/MPG.0000000000001789","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10139","key":"6978_CR36","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson JK, Beuers U, Jones DEJ et al (2018) Primary sclerosing cholangitis. Lancet 391(10139):2547\u20132559. https:\/\/doi.org\/10.1016\/S0140-6736(18)30300-3","journal-title":"Lancet"},{"issue":"2","key":"6978_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1148\/radiol.10091953","volume":"256","author":"M Dave","year":"2010","unstructured":"Dave M, Elmunzer BJ, Dwamena BA, Higgins PD (2010) Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology 256(2):387\u201396. https:\/\/doi.org\/10.1148\/radiol.10091953","journal-title":"Radiology"},{"issue":"3","key":"6978_CR38","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/jpn3.12319","volume":"79","author":"E Vanhanen","year":"2024","unstructured":"Vanhanen E, Ovissi A, Kolho KL, Tenca A (2024) Assessment of disease severity with magnetic resonance cholangiography in pediatric-onset primary sclerosing cholangitis. J Pediatr Gastroenterol Nutr 79(3):644\u2013651. https:\/\/doi.org\/10.1002\/jpn3.12319","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"6978_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/PAP.0000000000000500","volume":"32","author":"D Myoteri","year":"2025","unstructured":"Myoteri D, Sakellariou S, Tiniakos DG (2025) Histopathology of autoimmune hepatitis: an update. Adv Anat Pathol 32(6):414\u2013426. https:\/\/doi.org\/10.1097\/PAP.0000000000000500","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"6978_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1055\/s-0029-1233532","volume":"29","author":"C Wiegard","year":"2009","unstructured":"Wiegard C, Schramm C, Lohse AW (2009) Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future. Semin Liver Dis 29(3):254\u2013261. https:\/\/doi.org\/10.1055\/s-0029-1233532","journal-title":"Semin Liver Dis"},{"issue":"1","key":"6978_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3350\/cmh.2023.0325","volume":"30","author":"S Ahn","year":"2024","unstructured":"Ahn S, Jeong SH, Cho EJ, Lee K, Kim G, Kim H (2024) Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity. Clin Mol Hepatol 30(1):37\u201348. https:\/\/doi.org\/10.3350\/cmh.2023.0325","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"6978_CR42","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"AW Lohse","year":"2022","unstructured":"Lohse AW, Sebode M, Bhathal PS, Clouston AD, Dienes HP, Jain D, Gouw ASH, Guindi M, Kakar S, Kleiner DE, Krech T, Lackner C, Longerich T, Saxena R, Terracciano L, Washington K, Weidemann S, H\u00fcbscher SG, Tiniakos D (2022) Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology. Liver Int 42(5):1058\u20131069. https:\/\/doi.org\/10.1111\/liv.15217","journal-title":"Liver Int"},{"issue":"5","key":"6978_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/modpathol.2016.267","volume":"30","author":"D Balitzer","year":"2017","unstructured":"Balitzer D, Shafizadeh N, Peters MG, Ferrell LD, Alshak N, Kakar S (2017) Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the International Autoimmune Hepatitis Group and proposal for new histologic criteria. Mod Pathol 30(5):773\u2013783. https:\/\/doi.org\/10.1038\/modpathol.2016.267","journal-title":"Mod Pathol"},{"key":"6978_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.humpath.2024.03.003","volume":"146","author":"S Yu","year":"2024","unstructured":"Yu S, Vidal B, Peric M, Rosenbaum MW, Cates JMM, Gonzalez RS (2024) Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses. Hum Pathol 146:8\u201314. https:\/\/doi.org\/10.1016\/j.humpath.2024.03.003","journal-title":"Hum Pathol"},{"key":"6978_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1733006","volume":"12","author":"Y Yang","year":"2026","unstructured":"Yang Y, Yang F, Yang M, Liu Z, Liu S, Lian L, Chang B, Shen L, Tian H, Liang Q, Chen S, Dong S, Li C, Xie H, Zhong Y, Zou Z, Sun Y, Zhu Y (2026) Clinical characteristics and outcomes in 50 children with autoimmune hepatitis: a retrospective study from a single centre in China. Front Med (Lausanne) 12:1733006. https:\/\/doi.org\/10.3389\/fmed.2025.1733006","journal-title":"Front Med (Lausanne)"},{"key":"6978_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jpeds.2019.11.028","volume":"218","author":"A Di Giorgio","year":"2020","unstructured":"Di Giorgio A, Hadzic N, Dhawan A, Deheragoda M, Heneghan MA, Vergani D, Mieli-Vergani G, Samyn M (2020) Seamless management of juvenile autoimmune liver disease: long-term medical and social outcome. J Pediatr 218:121-129.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2019.11.028","journal-title":"J Pediatr"},{"issue":"5","key":"6978_CR47","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jhep.2023.01.013","volume":"78","author":"G Maggiore","year":"2023","unstructured":"Maggiore G, Bernard O, Mosca A, Ballot E, Johanet C, Jacquemin E (2023) Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood. J Hepatol 78(5):979\u2013988. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.013","journal-title":"J Hepatol"},{"issue":"5","key":"6978_CR48","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1007\/s10620-018-5011-x","volume":"63","author":"C Efe","year":"2018","unstructured":"Efe C, Taii HA, Ytting H, Aehling N, Bhanji RA, Hagstr\u00f6m H, Purnak T, Muratori L, Werner M, Muratori P, Klintman D, Schiano TD, Montano-Loza AJ, Berg T, Larsen FS, Alkhouri N, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S (2018) Tacrolimus and mycophenolate mofetil as second-line therapies for pediatric patients with autoimmune hepatitis. Dig Dis Sci 63(5):1348\u20131354. https:\/\/doi.org\/10.1007\/s10620-018-5011-x","journal-title":"Dig Dis Sci"},{"issue":"3","key":"6978_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011343.pub2","volume":"3","author":"F Saffioti","year":"2017","unstructured":"Saffioti F, Gurusamy KS, Hawkins N et al (2017) Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis. Cochrane Database Syst Rev 3(3):CD011343. https:\/\/doi.org\/10.1002\/14651858.CD011343.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"6978_CR50","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","volume":"129","author":"R Olsson","year":"2005","unstructured":"Olsson R, Boberg KM, de Muckadell OS et al (2005) High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 129(5):1464\u20131472. https:\/\/doi.org\/10.1053\/j.gastro.2005.08.017","journal-title":"Gastroenterology"},{"issue":"3","key":"6978_CR51","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.23082","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Kowdley KV, Luketic VA et al (2009) High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 50(3):808\u2013814. https:\/\/doi.org\/10.1002\/hep.23082","journal-title":"Hepatology"},{"issue":"3","key":"6978_CR52","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/hep.31560","volume":"73","author":"MR Deneau","year":"2021","unstructured":"Deneau MR, Mack C et al (2021) Oral vancomycin, ursodeoxycholic acid, or no therapy for pediatric primary sclerosing cholangitis: a matched analysis. Hepatology 73(3):1061\u20131073. https:\/\/doi.org\/10.1002\/hep.31560","journal-title":"Hepatology"},{"key":"6978_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jpeds.2019.01.039","volume":"209","author":"M Deneau","year":"2019","unstructured":"Deneau M, Perito E, Ricciuto A et al (2019) Ursodeoxycholic acid therapy in pediatric primary sclerosing cholangitis: predictors of gamma glutamyltransferase normalization and favorable clinical course. J Pediatr 209:92-96.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2019.01.039","journal-title":"J Pediatr"},{"issue":"10","key":"6978_CR54","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/apt.17936","volume":"59","author":"A Ricciuto","year":"2024","unstructured":"Ricciuto A, Liu K, El-Matary W et al (2024) Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): a matched analysis from the Paediatric PSC Consortium. Aliment Pharmacol Ther 59(10):1236\u20131247. https:\/\/doi.org\/10.1111\/apt.17936","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"6978_CR55","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000347","volume":"8","author":"A Shah","year":"2024","unstructured":"Shah A, Jones MP, Callaghan G, Fairlie T, Ma X, Culver EL, Stuart K, De Cruz P, O\u2019Beirne J, Tabibian JH, Dignass A, Canbay A, Gores GJ, Holtmann GJ (2024) Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: a systematic review and meta-analysis. Hepatol Commun 8(1):e0347. https:\/\/doi.org\/10.1097\/HC9.0000000000000347","journal-title":"Hepatol Commun"},{"issue":"10","key":"6978_CR56","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/j.cgh.2020.02.014","volume":"18","author":"CRH Hedin","year":"2020","unstructured":"Hedin CRH, Sado G, International PSC Study Group, Bergquist A et al (2020) Effects of tumor necrosis factor antagonists in patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 18(10):2295-2304.e2. https:\/\/doi.org\/10.1016\/j.cgh.2020.02.014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"6978_CR57","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/MPG.0000000000002855","volume":"71","author":"TJ Laborda","year":"2020","unstructured":"Laborda TJ, Ricciuto A, Aumar M, Carman N, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Koot BGP, Loomes KM, Lytvyak E, Martinez M, Miloh T, Montano-Loza AJ, Perito ER, Sathya P, Shah U, Shteyer E, Singh R, Taylor A, Valentino PL, Vitola B, Zerofsky M, Zizzo A, Deneau MR (2020) Vedolizumab therapy in children with primary sclerosing cholangitis: data from the Pediatric Primary Sclerosing Cholangitis Consortium. J Pediatr Gastroenterol Nutr 71(4):459\u2013464. https:\/\/doi.org\/10.1097\/MPG.0000000000002855","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6978_CR58","doi-asserted-by":"publisher","unstructured":"Tse CS, Loftus EV Jr, Raffals LE, Gossard AA, Lightner AL (2018) Effects of Vedolizumab, Adalimumab and Infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease. Aliment Pharmacol Ther 48(2):190\u2013195. https:\/\/doi.org\/10.1111\/apt.14829","DOI":"10.1111\/apt.14829"},{"issue":"6","key":"6978_CR59","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.dld.2025.03.021","volume":"57","author":"U Cucinotta","year":"2025","unstructured":"Cucinotta U, Dipasquale V, Mayer C, Alibrandi A, Pigneur B, Avril S, Bergamo C, Morello R, Rummele F, Romano C, Lacaille F (2025) Does the SCOPE (sclerosing cholangitis outcomes in pediatrics) index effectively predict later liver transplantation in children with sclerosing cholangitis? Dig Liver Dis 57(6):1247\u20131253. https:\/\/doi.org\/10.1016\/j.dld.2025.03.021","journal-title":"Dig Liver Dis"},{"issue":"9","key":"6978_CR60","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/lt.24490","volume":"22","author":"R Liberal","year":"2016","unstructured":"Liberal R, Vergani D, Mieli-Vergani G (2016) Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation. Liver Transpl 22(9):1275\u201383. https:\/\/doi.org\/10.1002\/lt.24490","journal-title":"Liver Transpl"},{"issue":"5","key":"6978_CR61","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/jpn3.70176","volume":"81","author":"ML Godet","year":"2025","unstructured":"Godet ML, Sarter H, Gottrand F, Saoudi C, Louvet A, Fumery M, Savoye G, Leroyer A, Gower-Rousseau C, Ley D, Aumar M (2025) Prognosis of pediatric-onset inflammatory bowel disease associated with primary sclerosing cholangitis: a population-based study. J Pediatr Gastroenterol Nutr 81(5):1180\u20131188. https:\/\/doi.org\/10.1002\/jpn3.70176","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"6978_CR62","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","volume":"17","author":"CL Bowlus","year":"2019","unstructured":"Bowlus CL, Lim JK, Lindor KD (2019) AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: expert review. Clin Gastroenterol Hepatol 17(12):2416\u20132422. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.011","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06978-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:02:07Z","timestamp":1780120927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06978-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["6978"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06978-4","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this article is a narrative review of the existing literature, ethics committee approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable, as this study did not involve human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"301"}}